Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-25-007989
Filing Date
2025-07-14
Accepted
2025-07-11 18:31:07
Documents
10

Document Format Files

Seq Description Document Type Size
1 4245B cvm_424b5.htm 424B5 482743
2 cvm_424b5img20.jpg GRAPHIC 6775
3 cvm_424b5img19.jpg GRAPHIC 36433
4 cvm_424b5img18.jpg GRAPHIC 43258
5 cvm_424b5img17.jpg GRAPHIC 36322
6 cvm_424b5img16.jpg GRAPHIC 37478
7 cvm_424b5img15.jpg GRAPHIC 22993
8 cvm_424b5img14.jpg GRAPHIC 27877
9 cvm_424b5img13.jpg GRAPHIC 27132
10 cvm_424b5img10.jpg GRAPHIC 4556
  Complete submission text file 0001654954-25-007989.txt   819317
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-265995 | Film No.: 251119873
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)